Advertisement

Topics

Mylan, Theravance Biopharma Partner to Submit NDA

05:07 EST 13 Nov 2017 | Contract Pharma

The drug is in development for the treatment of chronic obstructive pulmonary disease

Original Article: Mylan, Theravance Biopharma Partner to Submit NDA

NEXT ARTICLE

More From BioPortfolio on "Mylan, Theravance Biopharma Partner to Submit NDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...